Warby Parker Inc. (NYSE: WRBY) is a Consumer Cyclical company in the Specialty Retail industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | - | EPS (ttm) | 0.01 | Insider Own | 28.51% | Shs Outstand | 122.72M | Perf Week | 15.08% |
| Market Cap | 3.67B | Forward P/E | 51.21 | EPS next Y | 0.58 | Insider Trans | -2.36% | Shs Float | 93.48M | Perf Month | 2.40% |
| Enterprise Value | 3.59B | PEG | 65.24 | EPS next Q | - | Inst Own | - | Short Float | 19.11% | Perf Quarter | 36.06% |
| Income | 1.00M | P/S | 4.13 | EPS this Y | 4579.70% | Inst Trans | - | Short Ratio | 5.59 | Perf Half Y | 14.94% |
| Sales | 890.00M | P/B | 9.77 | EPS next Y | 24.85% | ROA | 0.18% | Short Interest | 17.86M | Perf YTD | 37.31% |
| Book/sh | 3.06 | P/C | 12.75 | EPS next 5Y | 45.86% | ROE | 0.37% | 52W High | 31.00 -3.48% | Perf Year | 26.78% |
| Cash/sh | 2.35 | P/FCF | 84.19 | EPS past 3/5Y | - | ROIC | -0.64% | 52W Low | 14.96 100.00% | Perf 3Y | 103.81% |
| Dividend Est. | - | EV/EBITDA | 66.47 | Sales past 3/5Y | 13.40% 17.22% | Gross Margin | 53.41% | Volatility | 4.92% 5.72% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 4.03 | EPS Y/Y TTM | 105.88% | Oper. Margin | -0.69% | ATR (14) | 1.58 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.03 | Sales Y/Y TTM | 15.43% | Profit Margin | 0.15% | RSI (14) | 66.71 | Recom | 2.47 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.33 | EPS Q/Q | 0.00% | SMA20 | 12.19% | Beta | 2.13 | Target Price | 31.00 |
| Payout | 0.00% | Debt/Eq | 0.55 | Sales Q/Q | 8.04% | SMA50 | 13.30% | Rel Volume | 0.95 | Prev Close | 28.28 |
| Employees | 2,218 | LT Debt/Eq | 0.55 | Earnings | Aug 06 | SMA200 | 24.09% | Avg Volume | 3.29M | Price | 29.92 |
| IPO Date | Sep 29, 2021 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 19.45% 1.26% | Net Debt/EBITDA | -0.94 | Volume | 3,142,824 | Change | 5.80% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| May-22-26 | Reiterated | China Renaissance Securities (US) Inc. | $30 | |
| May-08-26 | Reiterated | Telsey Advisory | Outperform | $32 → $33 |
| May-08-26 | Reiterated | UBS | Neutral | $20 → $27 |
| May-07-26 | Reiterated | BTIG | Buy | $32 → $34 |
| Feb-25-26 | Reiterated | UBS | Neutral | $23 → $20 |
| Dec-17-25 | Reiterated | Telsey Advisory | Outperform | $24 → $32 |
| Dec-17-25 | Reiterated | Robert W. Baird | $27 → $35 | |
| Dec-16-25 | Reiterated | Piper Sandler | Overweight | $25 → $32 |
| Dec-12-25 | Reiterated | Stifel Nicolaus | $19 → $25 | |
| Dec-11-25 | Reiterated | BTIG | Buy | $32 |
Warby Parker Inc. operates as a purveyor of optical products and related services. Their extensive product line includes prescription eyeglasses, sunglasses, and contact lenses, alongside specialized lens options such as light-responsive (photochromic) and blue-light-filtering variants. Customers can also acquire a variety of accessories, including protective cases, lens care kits equipped with anti-fog spray, pouches, and individual anti-fog lens sprays. Beyond product sales, Warby Parker facilitates direct-to-consumer eye examinations and vision assessments. These services are accessible through their physical retail locations, online platform, and dedicated mobile applications. By May 16, 2022, the company had established a network of 160 brick-and-mortar stores across the United States and Canada. Originally incorporated as JAND, Inc. in 2009, the organization officially rebranded to Warby Parker Inc. in June 2021. Its corporate headquarters are situated in New York, New York.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 890 | 872 | 771 | 670 | 598 | 541 | 394 | 370 | |
| Cost of Goods Sold Incl. D&A | 415 | 401 | 344 | 305 | 257 | 223 | 162 | 147 | |
| Gross Profit | 476 | 471 | 427 | 365 | 341 | 318 | 232 | 223 | |
| Selling, General and Administrative Excl. Other | 477 | 476 | 440 | 422 | 452 | 461 | 288 | 225 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 4 | 0 | 17 | 15 | 0 | 0 | 0 | 0 | |
| Operating Income | -6 | -5 | -30 | -72 | -111 | -144 | -56 | -2 | |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Unusual Expense | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 8 | 8 | 11 | 9 | 1 | 0 | 0 | 2 | |
| Net Income Before Taxes | 2 | 3 | -20 | -63 | -110 | -144 | -56 | 0 | |
| Income Taxes | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |
| Consolidated Net Income | 1 | 2 | -20 | -63 | -110 | -144 | -56 | 0 | |
| Net Income From Continuing Operations | 1 | 2 | -20 | -63 | -110 | -144 | -56 | 0 | |
| Net Income | 1 | 2 | -20 | -63 | -110 | -144 | -56 | 0 | |
| EPS (Recurring) | 0.01 | 0.01 | -0.17 | -0.54 | -0.96 | -1.39 | -0.50 | -0.52 | |
| EPS (Basic, Before Extraordinaries) | 0.01 | 0.01 | -0.17 | -0.54 | -0.96 | -1.39 | -0.50 | -0.52 | |
| EPS (Diluted) | 0.01 | 0.01 | -0.17 | -0.54 | -0.96 | -1.39 | -0.50 | -0.52 | |
| EBITDA | 54 | 53 | 26 | -24 | -78 | -122 | -37 | 13 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 2,992.00 | 1,663.36 | — | — | — | — | — | — | |
| Price To Sales Ratio | 4.14 | 3.07 | 3.77 | 2.46 | 2.59 | 9.81 | — | — | |
| Gross Margin | 53.48 | 54.01 | 55.38 | 54.48 | 57.02 | 58.78 | 58.88 | 60.27 | |
| Operating Margin | -0.67 | -0.57 | -3.89 | -10.75 | -18.56 | -26.62 | -14.21 | -0.54 | |
| Net Margin | 0.11 | 0.23 | -2.59 | -9.40 | -18.39 | -26.62 | -14.21 | 0.00 | |
| Shares Outstanding | 123 | 123 | 120 | 117 | 115 | 114 | 111 | 111 | |
| Market Capitalization | 3,680 | 2,680 | 2,905 | 1,650 | 1,551 | 5,308 | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Gilboa David Abraham | Co-Chief Executive Officer | Jul 06 '26 | Option Exercise | 0.00 | 54,347 | 0 | 4,609,751 | Jul 08 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Jul 06 '26 | Sale | 29.99 | 9,200 | 275,908 | 31,112 | Jul 08 |
| Gilboa David Abraham | Co-Chief Executive Officer | Jul 06 '26 | Sale | 29.84 | 54,347 | 1,621,714 | 31,112 | Jul 08 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Jul 01 '26 | Sale | 29.61 | 217,667 | 6,445,120 | 31,112 | Jul 02 |
| Gilboa David Abraham | Co-Chief Executive Officer | Jul 01 '26 | Option Exercise | 0.00 | 117,221 | 0 | 4,769,150 | Jul 02 |
| Gilboa David Abraham | Co-Chief Executive Officer | Jul 01 '26 | Sale | 29.69 | 242,221 | 7,191,541 | 31,112 | Jul 02 |
| Raider Jeffrey Jacob | Director | Jul 01 '26 | Sale | 29.72 | 22,500 | 668,700 | 435,201 | Jul 02 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Jun 29 '26 | Option Exercise | 0.00 | 36,300 | 0 | 95,759 | Jul 01 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Jun 29 '26 | Sale | 30.04 | 36,300 | 1,090,452 | 59,459 | Jul 01 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Jun 18 '26 | Option Exercise | 0.00 | 200,000 | 0 | 3,177,577 | Jun 23 |
| Briggs Teresa | Director | Jun 16 '26 | Sale | 25.94 | 5,000 | 129,683 | 48,883 | Jun 18 |
| Moon Youngme E | Director | Jun 12 '26 | Sale | 26.53 | 10,000 | 265,300 | 26,061 | Jun 12 |
| Gilboa David Abraham | Co-Chief Executive Officer | Jun 02 '26 | Option Exercise | 0.00 | 65,439 | 0 | 4,675,566 | Jun 04 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Jun 02 '26 | Option Exercise | 0.00 | 65,439 | 0 | 3,001,214 | Jun 04 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | May 19 '26 | Sale | 30.03 | 63,040 | 1,893,091 | 50,165 | May 21 |